Cell Therapy Project Manager
Kuopio Center for Gene and Cell Therapy (KCT) is a world-renowned research company located in Kuopio, Finland. Our mission is to conduct high-level research on translational fields of gene and cell therapy. KCT provides an exciting environment for applied research of ATMPs (Advanced Therapy Medicinal Products), discovering, establishing and developing them through Phase I / IIa clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector.
We are currently recruiting a competent Cell Therapy Project Manager to strengthen our Cell Development team.
Purpose of the position:
Managing Cell Therapy project operations and all activities around the responsible area. Ensuring that business needs are met in project management, and coordinate/lead projects to meet agreed targets while ensuring compliance.
Principal tasks, responsibilities, and authorities:
- Utilize project management tools and methodology to ensure proper schedule, budget, and cost. Prepare project scope, resource needs, economic evaluation, and timeline. Ensure that projects meet business as well as quality and safety requirements.
- Manage activities directed toward Cell Therapy continuity and balance: resource planning, scheduling, and organizing work.
- Excellent stakeholder management skills – external and internal.
- Responsible for keeping the Scientific Director informed of responsible areas progress and issues.
- Generate, review, develop, and approve related documentation and presentation.
- Coordinate and integrate with other KCT function areas to ensure support in attaining output, productivity, and quality.
- As an employee at KCT the continuous improvement of company culture and business processes according to company values and respective plans.
This position reports to the Scientific Director.
In order to succeed you need to have a:
- Master’s degree in relevant field.
- A minimum of 5 years of relevant experience in the diversified industry. Experience in Project Management is a must.
- Ability to influence and work across organizational boundaries and beyond.
- An entrepreneurial attitude with proven track record in solving problems strategically.
- Excellent communication skills. The position requires an ability to absorb and handle complex information and to translate this information into material which is both clearly structured and appealing to internal and external stakeholders.
Other attributes that help you to succeed:
- Action oriented and independent in collaborative manner
- Balances stakeholders
- Communicates effectively
- Tech Savvy
- Demonstrates self-awareness
We offer modern facilities, inspiring atmosphere and a skilful motivated team. We have extensive occupational healthcare, and we support our personnel’s well-being via ePassi-account. KCT is located in vibrant Kuopio, which offers a safe living environment, friendly atmosphere and clean nature. We hope you are able to work on-site but of course we have the possibility for telework couple days per week.
For more information regarding this position, you can contact Scientific Director Tuija Kekarainen on Mon-Wed between 17-18 CET, phone +358(0) 40 537 6603, tuija.kekarainen(at)kct.fi or Cell Therapy Process Development Manager Katja Sirviö on Mon-Wed between 16-17 CET, phone +358(0) 44 542 6276, email katja.sirvio(at)kct.fi.
Visit www.kct.fi or find us from LinkedIn!
What we are looking for
- suitable professional profile
- ePassi wellbeing benefit
- extensive occupational health-care
- physical and cultural free-time activities
KCT - Kuopio Center for Gene and Cell Therapy
Kuopio Center for Gene and Cell Therapy (KCT) is a world-renowned research institute located in Kuopio, Finland. Our mission is to conduct high-level research on basic and translational fields of gene- and cell therapy. The centre’s niche is in the interface between academic, basic research and the commercial biotechnology industry. KCT provides an exciting environment for applied research, discovering, establishing and developing them through Phase I clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector.